Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 The expression of hTid and ErbB-2 is inversely correlated in primary breast cancer (A) and in non mammary tumors (B).

From: In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor

A1 hTid (+) hTid (-) B2 hTid (+) hTid (-)
ErbB-2 (+) 2* 22* ErbB-2 (+) 2* 8*
ErbB-2 (-) 28* 6* ErbB-2 (-) 8* 0*
  1. *: number of cases; 1: p< 0,0001; 2: p< 0,007;